BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6696758)

  • 1. [3H] verapamil binding sites in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1984 Jan; 118(1):239-45. PubMed ID: 6696758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]nitrendipine receptors in skeletal muscle.
    Fosset M; Jaimovich E; Delpont E; Lazdunski M
    J Biol Chem; 1983 May; 258(10):6086-92. PubMed ID: 6304026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
    Galizzi JP; Fosset M; Lazdunski M
    Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
    Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
    J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization of the nitrendipine receptor from skeletal muscle transverse tubule membranes. Interactions with specific inhibitors of the voltage-dependent Ca2+ channel.
    Borsotto M; Norman RI; Fosset M; Lazdunski M
    Eur J Biochem; 1984 Aug; 142(3):449-55. PubMed ID: 6088224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific binding of the calcium antagonist [3H]verapamil to membrane fractions from plants.
    Andrejauskas E; Hertel R; Marmé D
    J Biol Chem; 1985 May; 260(9):5411-4. PubMed ID: 3157687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    Schmid A; Romey G; Barhanin J; Lazdunski M
    Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL; Schwartz A
    Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.
    Galizzi JP; Fosset M; Romey G; Laduron P; Lazdunski M
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7513-7. PubMed ID: 2429309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site.
    Zobrist RH; Giacomini KM; Nelson WL; Giacomini JC
    J Mol Cell Cardiol; 1986 Sep; 18(9):963-74. PubMed ID: 3783730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
    Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
    Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4,5-Triiodobenzoic acid affects [3H]verapamil binding to plant and animal membrane fractions and smooth muscle contraction.
    Andrejauskas E; Hertel R; Marmé D
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1269-75. PubMed ID: 3753496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-affinity binding sites for 1,4-dihydropyridines in skeletal muscle transverse tubule membranes revealed by changes in the fluorescence of felodipine.
    Dunn SM; Bladen C
    Biochemistry; 1992 Apr; 31(16):4039-45. PubMed ID: 1533154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
    Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
    Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.